The US electrophysiology (EP) diagnostic catheter market is expected to see consistent growth, particularly the segment for advanced EP diagnostic catheters, which is projected to experience a robust compound annual growth rate (CAGR) of 10% in market value from 2024 to 2033, according to forecasts from GlobalData, a leading data and analytics company.
GlobalData’s Electrophysiology Diagnostic Catheters Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 report reveals that US EP catheter market growth will be driven by increasing physician adoption, improved reimbursement policies, rising patient awareness and the launch of next-generation device innovations, highlighting the evolving landscape of cardiac care solutions.
Go deeper with GlobalData
EP diagnostic catheters, which are used for intracardiac sensing, recording, stimulation and mapping, are integral to diagnosing and managing arrhythmias. Arrhythmias – characterised by irregular heart rhythms – are increasingly prevalent in the US due to its ageing population and lifestyle-related factors such as hypertension, diabetes, obesity and physical inactivity.
EP procedures have become more reliable, with better patient outcomes
The US has the largest EP diagnostic catheter market globally, and benefits from a higher number of facilities and specialists compared to other countries. Advanced EP diagnostic catheters, while costlier, provide superior diagnostic capabilities, supporting their adoption despite price concerns.
Market drivers include the growing incidence of arrhythmias, increasing adoption of minimally invasive procedures, and the high effectiveness of EP diagnostic and ablation techniques. Additionally, improvements in catheter accuracy have made EP procedures more reliable, leading to better patient outcomes and reduced recurrence rates.
Despite its promising growth trajectory, the market faces notable challenges. The high cost of advanced EP diagnostic catheters could hinder accessibility, particularly in cost-sensitive healthcare settings.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataAdditionally, the growing adoption of reprocessed catheters — priced at nearly 50% less than new devices — creates a significant competitive hurdle for manufacturers. With reprocessing permitted in certain markets, it continues to impact potential revenue streams for original equipment manufacturers.
Overall, the US EP diagnostic catheter market’s growth will be bolstered by the advances in technology and procedure effectiveness. Continued innovations and cost-effective solutions are likely to address the market barriers and sustain long-term expansion.
